Category:

Upstart Names Paul Gu as CEO in Planned Leadership Transition

Upstart Holdings has announced that Co-Founder and Chief Technology Officer Paul Gu will become Chief Executive Officer, effective May 1, 2026. Co-Founder Dave Girouard will transition to Executive Chairman of the Board and serve as a special advisor to the CEO and leadership team. Girouard said, “Paul and I have been building Upstart side by side for almost 14 years and I expect we’ll continue to do so for another 14,” describing the move as a generational transition designed to support long-term founder leadership…

Posted On :
Category:

Viz.ai Names Jallel Harrati Chief Revenue Officer to Drive Enterprise AI Growth

Viz.ai has appointed Jallel Harrati as Chief Revenue Officer to lead its provider-focused commercial strategy. Harrati will oversee sales, customer success, and sales operations, supporting the expansion of Viz Assist, the company’s multimodal AI agent platform. The platform combines real-time clinical data with workflow tools, including ambient listening, chart summarization, guideline guidance, and coding support, to help clinicians work more efficiently…

Posted On :
Category:

ClearBank Taps Neil Drennan as CTO to Spearhead Technology Expansion

ClearBank has appointed Neil Drennan as Chief Technology Officer, tasking him with advancing the company’s cloud-based API and payments infrastructure as it expands across the UK and Europe. Drennan joins from Visa, where he served as Chief Technology Officer for Visa Cross Border Solutions and Currencycloud. He brings more than 15 years of experience spanning financial services and media, with prior roles at 10x Future Technologies and Amazon…

Posted On :
Category:

Sanofi Names Belén Garijo as Next CEO After Hudson Exit

Sanofi’s board has appointed Belén Garijo as Chief Executive Officer, with the transition set to take place after the company’s annual general meeting on April 29, 2026. Paul Hudson will step down on February 17, 2026, after the board chose not to renew his director mandate. During the interim period, Olivier Charmeil, Executive Vice President of General Medicines and a long-time member of the executive committee, will serve as interim CEO…

Posted On :
Category:

Circle Foundation Backs UN Digital Finance Platform to Improve Aid Delivery and Transparency

Circle Foundation, the philanthropic initiative backed by fintech company Circle Internet Group’s 1% equity commitment and the issuer of the USDC stablecoin, has announced its first international grant to support the United Nations’ Digital Hub of Treasury Solutions (DHoTS). Created in 2021 by UNHCR, DHoTS is a shared financial platform intended to streamline monetary transfers across the UN system and reduce dependence on legacy payment rails that can be slow and costly…

Posted On :
Category:

Pluralsight Names Jamie Roberts to Lead Global Marketing and Growth Strategy

Pluralsight has appointed Jamie Roberts as Chief Marketing Officer, tasking her with leading the company’s global marketing organization, including demand generation, product and content marketing, field programs, and digital experience. The company said the move supports its effort to align go-to-market execution with customer needs as it scales its business…

Posted On :
Category:

Zendesk Brings in Craig Flower to Drive Operations and AI Strategy

Zendesk has appointed Craig Flower as Chief Operating Officer to strengthen customer engagement, improve operational performance, and support its shift toward an AI-first approach. Flower, who previously served as the company’s Chief Information Officer, will oversee efforts to help customers adopt Zendesk’s AI tools, streamline internal processes, and improve service delivery. In announcing the move, Zendesk said Flower will also lead a new center of excellence to encourage knowledge sharing between employees and customers…

Posted On :
Category:

David Berman Takes Chief Development Role as Moderna Reshapes Leadership Team

Moderna has appointed David Berman, MD, PhD, as Chief Development Officer, adding him to its Executive Committee and placing him under Chief Executive Officer Stéphane Bancel. He succeeds Dr. Jacqueline Miller, who steps down as Chief Medical Officer. Announcing the move, Bancel said, “David’s leadership experience in oncology and infectious disease will be critical as we continue to invest and drive innovation across Moderna’s pipeline”…

Posted On :